<--- Back to Details
First PageDocument Content
37th United States Congress / False Claims Act / Office of Inspector General / Qui tam
Date: 2014-05-23 16:12:25
37th United States Congress
False Claims Act
Office of Inspector General
Qui tam

Pricing Issues Affecting Laboratories S. Craig Holden, Esquire OberKaler, A Professional Corporation 100 Light Street Baltimore, Maryland1120

Add to Reading List

Source URL: www.ober.com

Download Document from Source Website

File Size: 260,81 KB

Share Document on Facebook

Similar Documents

Subject:  Fraud, Waste and Abuse – CMP211 Policy Statement:

Subject: Fraud, Waste and Abuse – CMP211 Policy Statement:

DocID: 1roOx - View Document

QUALITEST PHARMACEUTICALS TO PAY $39 MILLION TO RESOLVE FALSE LABELING ALLEGATIONS The National Association of Medicaid Fraud Control Units (NAMFCU) announced on December 16, 2015 that 47 states and the federal governmen

QUALITEST PHARMACEUTICALS TO PAY $39 MILLION TO RESOLVE FALSE LABELING ALLEGATIONS The National Association of Medicaid Fraud Control Units (NAMFCU) announced on December 16, 2015 that 47 states and the federal governmen

DocID: 1r6HE - View Document

FAR Disclosure Requirements Requirement to Report Certain Violations of Criminal and Civil Law to the Office of Inspector General Federal Acquisition Rulerequires a government contractor to timely disclose, in

FAR Disclosure Requirements Requirement to Report Certain Violations of Criminal and Civil Law to the Office of Inspector General Federal Acquisition Rulerequires a government contractor to timely disclose, in

DocID: 1qy7N - View Document

CRP Guidelines for Loans to Officers

CRP Guidelines for Loans to Officers

DocID: 1qwfJ - View Document

W&C Standard Template

W&C Standard Template

DocID: 1qiLa - View Document